https://www.thebodypro.com/category/hiv-treatment-as-prevention/tag/news

The Latest

integrase inhibitor

This Week in HIV Research: The Fast-Acting Power of Integrase

April 9, 2020: Rapid efficacy of integrase-based treatment; a potent PrEP ad campaign in Chicago; more frequent STI screening for PrEP users; Ryan White funding fuels critical rural HIV care and services.

By Barbara Jungwirth and Myles Helfand
virology

This Week in HIV Research: Is Viral Suppression an STI Prevention Tool?

March 5, 2020: How U=U reduces more than HIV transmission; "other" HPV strain risks post-vaccination; vitamin E for nonalcoholic steatohepatitis; HCV therapy and increased cardiovascular risk.

By Barbara Jungwirth and Myles Helfand
men on beach

This Week in HIV Research: Do You Believe in U=U?

Feb. 27, 2020: U=U perception vs. reality; frequency of incorrect self-reported viral load levels; how HIV transmission cluster predicts care continuum gaps; integrase inhibitor uptake and discontinuation.

By Barbara Jungwirth and Myles Helfand
three human skeleton models doing "see no evil, hear no evil, speak no evil"

This Week in HIV Research: Bone Concerns Aren’t Just for Older Folks

Jan. 9, 2020: Bone loss after HIV treatment initiation; aging and antiretroviral dosage; more U=U evidence for women; viral suppression and executive function.

By Barbara Jungwirth and Myles Helfand
Scientist holding slide with blood sample in lab

This Week in HIV Research: U=U Grows Ever Stronger

Oct. 10, 2019: Long-term viral suppression = zero genital tract shedding among women; HIV treatment initiation and sexual risk among MSM; PrEP interest vs. uptake among trans women of color; polypharmacy among people living with HIV.

By Barbara Jungwirth and Myles Helfand
woman's hand dangling keys

This Week in HIV Research: New Keys to the Care Continuum

Sept. 12, 2019: Better virologic outcomes at coordinated walk-in facilities offering incentives; same-day PrEP initiation at STD clinics; U=U and "low drug regimens"; adherence trends among perinatally infected adolescents.

By Barbara Jungwirth and Myles Helfand
nurse looking at medical chart

This Week in HIV Research: What's in a Blip?

Aug. 29, 2019: Viral load blips, low-level viremia, and eventual virologic failure; pinpointing non-adherence as a cause of HIV treatment failure; HIV care costs vary widely throughout U.S.; Kaposi sarcoma incidence in the modern HIV treatment era.

By Barbara Jungwirth and Myles Helfand
man getting vaccine

Large Scale HIV Vaccine Trial Announced, But PrEP May Challenge Enrollment

Will potential study participants choose a vaccine trial over getting access to PrEP?

By Sony Salzman
The Next Frontier of U=U Science Img

The Next Frontier of U=U Science

Undetectable equals untransmittable (U=U) has improved HIV prevention and tackled stigma, but there are still a few questions to answer.

By Sony Salzman
Alison Rodger discusses PARTNER2 study findings during a press conference at AIDS 2018

Gay Men Cannot Get HIV From Partners Who Are Virally Suppressed, New Study Proves

Results from the PARTNER2 study, presented by Alison Rodger at AIDS 2018, yielded an equivalent level of confidence for gay men as it had for heterosexual couples in the original PARTNER study several years ago.

By Ace Robinson and Kenyon Farrow